Considering the selective expression of psoriasin in the epidermis and its chemoattractant and pro-angiogenic properties, this molecule may contribute possibly through a pro-inflammatory activity on keratinocytes to the development of clinical symptoms in SSc, such as alveolitis, telangiectasia, and pitting scars [158]. This evidence concerns the gene S100A7 and telangiectasis.